Gilead Sciences
GILD
#134
Rank
S$203.41 B
Marketcap
S$163.83
Share price
0.94%
Change (1 day)
20.52%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): S$8.85

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$8.89. In 2024 the company made an earnings per share (EPS) of S$0.49 a decrease over its 2023 EPS that were of S$5.91.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.851694.9%
2024S$0.49-91.65%
2023S$5.9123.98%
2022S$4.76-25.86%
2021S$6.424850%
2020S$0.13-97.64%
2019S$5.500.9%
2018S$5.4518.71%
2017S$4.59-64.88%
2016S$13.08-18.45%
2015S$16.0455.28%
2014S$10.33296.02%
2013S$2.6117.89%
2012S$2.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.34 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.70-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.67-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.63 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.79 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$12.14 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.18-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$22.08 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.62-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA